Compare GATX & MIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GATX | MIR |
|---|---|---|
| Founded | 1898 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Transportation Services | Industrial Machinery/Components |
| Sector | Consumer Discretionary | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.5B | 6.0B |
| IPO Year | N/A | N/A |
| Metric | GATX | MIR |
|---|---|---|
| Price | $169.29 | $24.35 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 7 |
| Target Price | ★ $192.00 | $28.29 |
| AVG Volume (30 Days) | 164.0K | ★ 3.3M |
| Earning Date | 01-22-2026 | 10-28-2025 |
| Dividend Yield | ★ 1.45% | N/A |
| EPS Growth | ★ 14.17 | N/A |
| EPS | ★ 8.56 | 0.10 |
| Revenue | ★ $1,704,900,000.00 | $902,300,000.00 |
| Revenue This Year | $11.64 | $8.15 |
| Revenue Next Year | $15.03 | $19.02 |
| P/E Ratio | ★ $19.68 | $243.04 |
| Revenue Growth | ★ 10.66 | 7.82 |
| 52 Week Low | $139.44 | $12.00 |
| 52 Week High | $178.26 | $30.28 |
| Indicator | GATX | MIR |
|---|---|---|
| Relative Strength Index (RSI) | 64.69 | 44.81 |
| Support Level | $163.47 | $24.52 |
| Resistance Level | $171.13 | $26.36 |
| Average True Range (ATR) | 3.20 | 0.99 |
| MACD | 1.14 | -0.04 |
| Stochastic Oscillator | 87.64 | 0.74 |
GATX Corp is a provider of railcar leasing and maintenance services. GATX operates in business segments including rail North America, rail international, Engine Leasing, and others. The rail business offers railcar leasing and maintenance, as well as asset-related, financial, and management services. The company owns and leases fleets in North America, Europe, and Asia, which consist of tank and freight railcars. Industries served include refining and petroleum, chemicals and plastics, railroads and other transportation, mining, and food and agriculture.
Mirion Technologies Inc provides products, services, and software that allow customers to safely leverage the power of ionizing radiation for applications that benefit the health, safety, vitality, and technological progress of the human experience. The Company manages its operations through two segments: Nuclear & Safety and Medical. The Medical segment improves the quality and safety of cancer care delivery and supports applications across medical diagnostics and practitioner safety. The Nuclear & Safety segment powers advancements in nuclear energy and critical radiation safety, measurement and analysis applications across laboratories, research and other industrial markets such as defense.